SCHEMBL24485148

SCHEMBL24485148

Cc1oc2ccc(OCc3cccnc3C(F)(F)F)cc2c1C(=O)NC1(CO)CC1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC26A4 O43511 7/20 0.48
KMT2A Q03164 6/20 0.46
MEN1 O00255 5/20 0.46
MAPT P10636 4/20 0.44
LMNA P02545 3/20 0.44
TSHR P16473 2/20 0.44
CASP3 P42574 1/20 0.42
SENP8 Q96LD8 1/20 0.42
SENP7 Q9BQF6 1/20 0.42
SENP6 Q9GZR1 1/20 0.42
SMN1; SMN2 Q16637 2/20 0.42
NPSR1 Q6W5P4 2/20 0.42
KDM4E B2RXH2 1/20 0.42
POLB P06746 2/20 0.41
HTT P42858 1/20 0.41
GAA P10253 2/20 0.41
L3MBTL1 Q9Y468 1/20 0.40
PTGS2 P35354 1/20 0.40
BLM P54132 1/20 0.39
ATM Q13315 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29629904 1.00 SLC26A4 (0.48) SLC26A4KMT2AMEN1MAPTLMNA
SCHEMBL24485594 0.97 SLC26A4 (0.47) SLC26A4KMT2AMEN1MAPTLMNA
SCHEMBL29629959 0.97 SLC26A4 (0.47) SLC26A4KMT2AMEN1MAPTLMNA
SCHEMBL24484887 0.95 SLC26A4 (0.45) SLC26A4KMT2AMEN1MAPTLMNA
SCHEMBL24484981 0.94 SLC26A4 (0.47) SLC26A4KMT2AMEN1MAPTLMNA
SCHEMBL29629907 0.94 SLC26A4 (0.47) SLC26A4KMT2AMEN1MAPTLMNA
SCHEMBL24484976 0.93 SLC26A4 (0.45) SLC26A4KMT2AMEN1MAPTLMNA
SCHEMBL24484319 0.93 SLC26A4 (0.46) SLC26A4KMT2AMEN1MAPTLMNA
SCHEMBL24485633 0.92 SLC26A4 (0.43) SLC26A4KMT2AMEN1MAPTLMNA
SCHEMBL29629774 0.92 SLC26A4 (0.43) SLC26A4KMT2AMEN1MAPTLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022112352-A1 HETEROCYCLE DERIVATIVES FOR TREATING TRPM3 MEDIATED DISORDERS KATHOLIEKE UNIVERSITEIT LEUVEN (BE) 2022-06-02 WO disclosed